Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2014

01-07-2014 | Article

Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004–2012

Authors: M.-R. Lee, H.-C. Wang, C.-Y. Yang, C.-K. Lin, H.-Y. Kuo, J.-C. Ko, W.-H. Sheng, L.-N. Lee, C.-J. Yu, P.-R. Hsueh

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2014

Login to get access

Abstract

Stenotrophomonas maltophilia can cause various clinical diseases; however, pleural infections due to S. maltophilia are rare. We evaluated the clinical characteristics and outcomes of patients with pleural infections (complicated parapneumonic effusion or empyema) due to S. maltophilia who were treated at a medical center in Taiwan from 2004 to 2012. During the study period, 40 patients were treated for pleural infections due to S. maltophilia. The incidence of S. maltophilia pleural infections ranged from 2.66 per 1,000,000 patient-days in 2009 to 12.44 per 1,000,000 patient-days in 2011. Most of the patients with S. maltophilia pleural infections were immunocompromised male adults and all of the infections were acquired in healthcare settings. The majority of patients had polymicrobial pleural infections (n = 31, 77.5 %) and the most common pathogen was Pseudomonas aeruginosa (n = 12). The causes of pleural infections due to S. maltophilia were pneumonia due to S. maltophilia in two patients (5 %), post-surgical/tube thoracostomy in 26 (65 %) patients, and fistula (bronchopleural, esophagopleural and biliopleural) in 12 (30 %) patients. The 14-day and 30-day mortality rates were 32.5 % and 42.5 %, respectively. Pleural infections due to S. maltophilia are most commonly the result of surgical procedures, thoracostomy, and underlying fistulas. These infections are associated with a high mortality rate, especially among immunocompromised patients.
Literature
2.
go back to reference Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312–323PubMedCrossRef Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312–323PubMedCrossRef
4.
go back to reference Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, Wu DC, Wang TP, Lin CM, Lin WR, Chen YH (2013) Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect S1684–1182(12)00175-2 Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, Wu DC, Wang TP, Lin CM, Lin WR, Chen YH (2013) Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect S1684–1182(12)00175-2
5.
go back to reference Wu H, Wang JT, Shiau YR, Wang HY, Lauderdale TL, Chang SC, Hospitals TSAR (2012) A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect 45:120–126PubMedCrossRef Wu H, Wang JT, Shiau YR, Wang HY, Lauderdale TL, Chang SC, Hospitals TSAR (2012) A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect 45:120–126PubMedCrossRef
6.
go back to reference Fujita J, Yamadori I, Xu G, Hojo S, Negayama K, Miyawaki H, Yamaji Y, Takahara J (1996) Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir Med 90:35–38PubMedCrossRef Fujita J, Yamadori I, Xu G, Hojo S, Negayama K, Miyawaki H, Yamaji Y, Takahara J (1996) Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir Med 90:35–38PubMedCrossRef
7.
go back to reference Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A (2006) Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med 34:2959–2966PubMed Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A (2006) Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med 34:2959–2966PubMed
8.
go back to reference Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602–1609PubMedCrossRef Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602–1609PubMedCrossRef
9.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef
10.
go back to reference Lee MR, Chen CM, Chuang TY, Huang YT, Hsueh PR (2013) Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009–2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and beta-lactam resistance. Int J Antimicrob Agents 42:395–402PubMedCrossRef Lee MR, Chen CM, Chuang TY, Huang YT, Hsueh PR (2013) Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009–2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and beta-lactam resistance. Int J Antimicrob Agents 42:395–402PubMedCrossRef
11.
go back to reference Lee MR, Huang YT, Liao CH, Chuang TY, Wang WJ, Lee SW, Lee LN, Hsueh PR (2012) Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010. J Clin Microbiol 50:2053–2055PubMedCrossRefPubMedCentral Lee MR, Huang YT, Liao CH, Chuang TY, Wang WJ, Lee SW, Lee LN, Hsueh PR (2012) Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010. J Clin Microbiol 50:2053–2055PubMedCrossRefPubMedCentral
12.
go back to reference Lisboa T, Waterer GW, Lee YC (2011) Pleural infection: changing bacteriology and its implications. Respirology 16:598–603PubMedCrossRef Lisboa T, Waterer GW, Lee YC (2011) Pleural infection: changing bacteriology and its implications. Respirology 16:598–603PubMedCrossRef
13.
go back to reference Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ, First Multicenter Intrapleural Sepsis Trial (MIST1) Group (2005) U.K. (2005) Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865–874PubMedCrossRef Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ, First Multicenter Intrapleural Sepsis Trial (MIST1) Group (2005) U.K. (2005) Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865–874PubMedCrossRef
14.
go back to reference Tu CY, Hsu WH, Hsia TC, Chen HJ, Chiu KL, Hang LW, Shih CM (2006) The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 32:570–576PubMedCrossRef Tu CY, Hsu WH, Hsia TC, Chen HJ, Chiu KL, Hang LW, Shih CM (2006) The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 32:570–576PubMedCrossRef
15.
go back to reference Mukhopadhyay C, Bhargava A, Ayyagari A (2003) Novel healthcare-associated infections by Stenotrophomonas maltophilia: first reported case from Lucknow, North India. J Clin Microbiol 41:3989–3990PubMedCrossRefPubMedCentral Mukhopadhyay C, Bhargava A, Ayyagari A (2003) Novel healthcare-associated infections by Stenotrophomonas maltophilia: first reported case from Lucknow, North India. J Clin Microbiol 41:3989–3990PubMedCrossRefPubMedCentral
16.
go back to reference Bini A, Grazia M, Petrella F, Stella F, Bazzocchi R (2004) Spontaneous biliopneumothorax (thoracobilia) following gastropleural fistula due to stomach perforation by nasogastric tube. Ann Thorac Surg 78:339–341PubMedCrossRef Bini A, Grazia M, Petrella F, Stella F, Bazzocchi R (2004) Spontaneous biliopneumothorax (thoracobilia) following gastropleural fistula due to stomach perforation by nasogastric tube. Ann Thorac Surg 78:339–341PubMedCrossRef
17.
go back to reference Liu Z, Zhao Z, Xiong J (1999) Analysis of clinical characteristics and drug sensitivity tests of lower respiratory tract infection by Xanthomonas maltophilia. Zhonghua Jie He He Hu Xi Za Zhi 22:211–213PubMed Liu Z, Zhao Z, Xiong J (1999) Analysis of clinical characteristics and drug sensitivity tests of lower respiratory tract infection by Xanthomonas maltophilia. Zhonghua Jie He He Hu Xi Za Zhi 22:211–213PubMed
18.
go back to reference Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G (2009) Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 4:1103–1109PubMedCrossRef Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G (2009) Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 4:1103–1109PubMedCrossRef
19.
go back to reference Rousseau A, Morcos M, Amrouche L, Foïs E, Casetta A, Rio B, Le Tourneaua A, Molina T, Rabbat A, Marie JP, Audouin J (2004) Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma 45:1293–1296PubMedCrossRef Rousseau A, Morcos M, Amrouche L, Foïs E, Casetta A, Rio B, Le Tourneaua A, Molina T, Rabbat A, Marie JP, Audouin J (2004) Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma 45:1293–1296PubMedCrossRef
20.
go back to reference Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A (2012) Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis 14:355–363PubMedCrossRef Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A (2012) Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis 14:355–363PubMedCrossRef
21.
go back to reference Jamrozy-Witkowska AM, Grzybowski A, Grabska-Liberek I, Pawlik-Sobecka LA, Krzyzanowska-Berkowska PP (2010) Co-existence of Staphylococcus spp and Stenotrophomonas maltophilia infection in persistent endophthalmitis after cataract surgery. Clin Exp Optom 293:473–475CrossRef Jamrozy-Witkowska AM, Grzybowski A, Grabska-Liberek I, Pawlik-Sobecka LA, Krzyzanowska-Berkowska PP (2010) Co-existence of Staphylococcus spp and Stenotrophomonas maltophilia infection in persistent endophthalmitis after cataract surgery. Clin Exp Optom 293:473–475CrossRef
22.
go back to reference Horster S, Bader L, Seybold U, Eschler I, Riedel KG, Bogner JR (2009) Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients. Infection 37:117–122PubMedCrossRef Horster S, Bader L, Seybold U, Eschler I, Riedel KG, Bogner JR (2009) Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients. Infection 37:117–122PubMedCrossRef
23.
go back to reference Sood S, Vaid VK, Bhartiya H (2013) Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure. J Clin Diagn Res 7:1696–1697PubMedPubMedCentral Sood S, Vaid VK, Bhartiya H (2013) Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure. J Clin Diagn Res 7:1696–1697PubMedPubMedCentral
24.
go back to reference Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A (2005) Life-threatening chronic enteritis due to colonization of the small bowel with Stenotrophomonas maltophilia. Gastroenterology 129:706–712 Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A (2005) Life-threatening chronic enteritis due to colonization of the small bowel with Stenotrophomonas maltophilia. Gastroenterology 129:706–712
25.
go back to reference Denton M, Kerr KG (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57–80PubMedPubMedCentral Denton M, Kerr KG (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57–80PubMedPubMedCentral
26.
go back to reference Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ (1995) Stenotrophomonas maltophilia: an unusual cause of biliary sepsis. Clin Infect Dis 21:1032–1034PubMedCrossRef Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ (1995) Stenotrophomonas maltophilia: an unusual cause of biliary sepsis. Clin Infect Dis 21:1032–1034PubMedCrossRef
27.
go back to reference Stanojevic S, Ratjen F, Stephens D, Lu A, Yau Y, Tullis E, Waters V (2013) Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. J Cyst Fibros 12(6):575–583 Stanojevic S, Ratjen F, Stephens D, Lu A, Yau Y, Tullis E, Waters V (2013) Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. J Cyst Fibros 12(6):575–583
28.
go back to reference Fihman V, Le Monnier A, Corvec S, Jaurequy F, Tankovic J, Jacquier H (2012) Stenotrophomonas maltophilia–the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect 64:391–398PubMedCrossRef Fihman V, Le Monnier A, Corvec S, Jaurequy F, Tankovic J, Jacquier H (2012) Stenotrophomonas maltophilia–the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. J Infect 64:391–398PubMedCrossRef
29.
go back to reference Rattanaumpawan P, Ussavasodhi P, Kiratisin P, Aswapokee N (2013) Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria. BMC Infect Dis 13:167PubMedCrossRefPubMedCentral Rattanaumpawan P, Ussavasodhi P, Kiratisin P, Aswapokee N (2013) Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria. BMC Infect Dis 13:167PubMedCrossRefPubMedCentral
30.
go back to reference Wang WS, Liu CP, Lee CM, Huang FY (2004) Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37:359–365PubMed Wang WS, Liu CP, Lee CM, Huang FY (2004) Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 37:359–365PubMed
31.
go back to reference LiPuma JJ (2003) Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 24:681–692PubMedCrossRef LiPuma JJ (2003) Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 24:681–692PubMedCrossRef
32.
go back to reference LiPuma JJ (2000) Expanding microbiology of pulmonary infection in cystic fibrosis. Pediatr Infect Dis J 19:473–474PubMedCrossRef LiPuma JJ (2000) Expanding microbiology of pulmonary infection in cystic fibrosis. Pediatr Infect Dis J 19:473–474PubMedCrossRef
33.
go back to reference Tan R, Liu J, Li M, Huang J, Sun J, Qu H (2013) Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai. J Microbiol Immunol Infect S1684–1182(12)00241-1 Tan R, Liu J, Li M, Huang J, Sun J, Qu H (2013) Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai. J Microbiol Immunol Infect S1684–1182(12)00241-1
34.
go back to reference Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488–1495PubMedCrossRefPubMedCentral Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488–1495PubMedCrossRefPubMedCentral
35.
go back to reference Pathmanathan A, Waterer GW (2005) Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J 25:911–914PubMedCrossRef Pathmanathan A, Waterer GW (2005) Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J 25:911–914PubMedCrossRef
36.
go back to reference Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A (2007) Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. Eur J Clin Microbiol Infect Dis 26:13–20PubMedCrossRef Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A (2007) Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. Eur J Clin Microbiol Infect Dis 26:13–20PubMedCrossRef
37.
go back to reference Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systemic review. J Antimicrob Chemother 62:889–894PubMedCrossRef Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systemic review. J Antimicrob Chemother 62:889–894PubMedCrossRef
Metadata
Title
Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004–2012
Authors
M.-R. Lee
H.-C. Wang
C.-Y. Yang
C.-K. Lin
H.-Y. Kuo
J.-C. Ko
W.-H. Sheng
L.-N. Lee
C.-J. Yu
P.-R. Hsueh
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2060-8

Other articles of this Issue 7/2014

European Journal of Clinical Microbiology & Infectious Diseases 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine